Snoop Dogg is set to take center stage at the Saenger Theater in New Orleans for the primetime NFL Honors that recognizes the ...

Now comes Kirton and his advisory council’s most ambitious project, the virtual ALS Super Auction, between Feb. 6-20. Every ...

Repeated brain injury resulted in SOD1-ALS mice showing greater weight loss, an earlier tremor in the hind limbs, and ...

Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will participate in a fireside chat at the Oppenheimer 25 th Annual ...

Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...

Zydus Lifesciences Limited reports 30% profit increase, driven by US formulations business, with strong financial position ...

The Valentine Plunge has raised nearly $5 million for the Joan Dancy and P.A.L.S. (People with ALS) Foundation.

A patent has been granted in the US covering the use of Neurizon’s lead drug candidate NUZ-001 in neurodegenerative diseases ...

Second Clinical Trial Getting Underway for PathMaker's Non-Invasive ALS Treatment Platform. BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. ("PathMaker”), ...

A 3D model accurately mimicking the Blood-Brain Barrier (BBB) in a laboratory environment has been successfully developed by ...

Medicare is a government-sponsored health program for people 65 and older, as well as those with certain disabilities, ...